Life sciences commercial organizations can now forecast sales, predict churn, analyze brand propensity and launch new products with BirdzAI PISCATAWAY TOWNSHIP, N.J.–(BUSINESS WIRE)–#AI—P360, a leading developer of technology for life sciences companies, today announced major updates to its sales enablement platform BirdzAI.
A former top official in the NSC has accused Trump Administration officials of political intervention in the pre-publication review process for John Bolton’s book. — ABC News: Top Stories
Doctors treating Aleksei Navalny said he had been discharged after 32 days of treatment and could make a full recovery. NYT: Melissa Eddy
Johnson & Johnson plans to enroll 60,000 participants in its Phase 3 trials. Dr. Anthony Fauci and other top U.S. health officials are scheduled to testify before a Senate panel today. — NYT: Top Stories
A career official said political appointees “commandeered” the prepublication review process of John Bolton’s memoir. — NYT: Michael S. Schmidt and Charlie Savage
Justice Ruth Bader Ginsburg was to lay in repose outside the Supreme Court Wednesday for an unprecedented public viewing. — ABC News: Top Stories
Though his career was cut short by knee injuries, he was widely regarded as one of the greatest running backs in National Football League history. — NYT: George Vecsey
Immetas Therapeutics Announces Series A Financing to Advance Research on Inflammation Pathways in Aging and Develop Therapeutics for Cancer and Inflammatory Disease, EAST HANOVER, N.J.–(BUSINESS WIRE)–Immetas Therapeutics today announced it has raised a Series A financing of $11 million to advance research
Experts weigh in on what the future may hold amid the pandemic. — ABC News: Top Stories